Skip to main content

BOOTHBAY FUND MANAGEMENT, LLC

Position in RVMD — Revolution Medicines, Inc.

CIK 1549230 NEW YORK, NY

Position in RVMD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$42,653,363
+$16,595,707 QoQ
Shares Held
438,595
+34.1% QoQ
Ownership
0.206%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
6 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in RVMD Over Time

Shares Held

Position Value (USD)

Derivatives in RVMD

reported options exposure · as of Mar 31, 2026
CallValue
$4,891,675
CallShares
50,300
PutValue
$35,194,775
PutShares
361,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BOOTHBAY FUND MANAGEMENT, LLC holds $541,089,850 across 142 Biotechnology names. RVMD ranks #2 (7.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 RVMD
Revolution Medicines, Inc.
This page
438,595 $42,653,363

All Filings in RVMD

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $35,194,775 361,900
2026-03-31 $4,891,675 50,300
2026-03-31 $42,653,363 438,595
2025-12-31 $2,102,760 26,400
2025-12-31 $26,057,656 327,152
2025-09-30 $12,375,873 265,008
2025-09-30 $1,611,150 34,500
2025-06-30 $6,837,127 185,842
2025-03-31 $6,218,444 175,861
2023-09-30 $1,134,880 41,000